Sarcoidosis is a systemic granulomatous disease of unknown origin. To clarify its pathogenesis, we searched for known or unknown genes which are specifically expressed in sarcoidosis. Bronchoalveolar lavage (BAL) cells from 18 patients with sarcoidosis and 8 patients with various lung diseases were analyzed by differential display method. mRNA was extracted from BAL cells and reverse transcribed with 12 kinds of anchored primer, which theoretically cover all mRNAs, followed by polymerase chain reaction (PCR) with the anchored primer and a 10-mer arbitrary primer. PCR products were displayed on a polyacrylamide gel and fragments showing characteristic alterations in intensity between sarcoidosis and other patients were extracted, sequence...
Sarcoidosis is a systemic, granulomatous disease caused by unknown immunological abnormalities. The ...
The pathogenesis of sarcoidosis is still poorly understood. Genome-wide gene expression profiling ca...
Pulmonary hypertension (PH), when it complicates sarcoidosis, carries a poor prognosis, in part beca...
Sarcoidosis is a systemic granulomatous disease of unknown origin. To clarify its pathogenesis, we s...
RATIONALE: Approximately 60 to 70% of patients with pulmonary sarcoidosis have disease that resolves...
Rationale Despite the availability of multi-"omics" strategies, insights into the etiology and patho...
Abstract Background Sarcoidosis is a multisystem immu...
Sarcoidosis is an inflammatory granulomatous disease that primarily affects the lung. It has a world...
Idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis are typical interstitial lung diseases...
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis are typical interstitial l...
Pulmonary hypertension (PH), when it complicates sarcoidosis, carries a poor prognosis, in part beca...
Sarcoidosis is a multisystem immunological disorder, centred on the dysregulation of T cell activity...
Sarcoidosis is a granulomatous disorder of unknown etiology. Infection, genetic factors, autoimmunit...
BACKGROUND: Sarcoidosis is a multisystem immuno-inflammatory disorder of unknown etiology that most ...
Sarcoidosis is a granulomatous disease of unknown etiology, immunologically characterized by a Th1 i...
Sarcoidosis is a systemic, granulomatous disease caused by unknown immunological abnormalities. The ...
The pathogenesis of sarcoidosis is still poorly understood. Genome-wide gene expression profiling ca...
Pulmonary hypertension (PH), when it complicates sarcoidosis, carries a poor prognosis, in part beca...
Sarcoidosis is a systemic granulomatous disease of unknown origin. To clarify its pathogenesis, we s...
RATIONALE: Approximately 60 to 70% of patients with pulmonary sarcoidosis have disease that resolves...
Rationale Despite the availability of multi-"omics" strategies, insights into the etiology and patho...
Abstract Background Sarcoidosis is a multisystem immu...
Sarcoidosis is an inflammatory granulomatous disease that primarily affects the lung. It has a world...
Idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis are typical interstitial lung diseases...
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis are typical interstitial l...
Pulmonary hypertension (PH), when it complicates sarcoidosis, carries a poor prognosis, in part beca...
Sarcoidosis is a multisystem immunological disorder, centred on the dysregulation of T cell activity...
Sarcoidosis is a granulomatous disorder of unknown etiology. Infection, genetic factors, autoimmunit...
BACKGROUND: Sarcoidosis is a multisystem immuno-inflammatory disorder of unknown etiology that most ...
Sarcoidosis is a granulomatous disease of unknown etiology, immunologically characterized by a Th1 i...
Sarcoidosis is a systemic, granulomatous disease caused by unknown immunological abnormalities. The ...
The pathogenesis of sarcoidosis is still poorly understood. Genome-wide gene expression profiling ca...
Pulmonary hypertension (PH), when it complicates sarcoidosis, carries a poor prognosis, in part beca...